Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors

Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors

Breast cancer treatment using plant-virus-based nanoparticles (PVNPs) has achieved considerable success in preclinical studies. PVNP-based breast cancer therapies include non-targeted and targeted nanoplatforms for delivery of anticancer therapeutic chemo and immune agents and cancer vaccines for ac...

Full description

Bibliographic Details
Main Authors:	Mehdi Shahgolzari, Hassan Dianat-Moghadam, Afagh Yavari, Steven N. Fiering, Kathleen Hefferon
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Vaccines
Subjects:	plant viruses in situ vaccination immunomodulatory agent passive targeting active targeting
Online Access:	https://www.mdpi.com/2076-393X/10/9/1431

Similar Items

Plant Virus Nanoparticles Combat Cancer
by: Mehdi Shahgolzari, et al.
Published: (2023-07-01)

Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
by: Sulltana Jahan, et al.
Published: (2021-01-01)

Repurposing Plant Virus Nanoparticles
by: Kathleen L. Hefferon
Published: (2018-02-01)

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
by: Huang M, et al.
Published: (2023-07-01)

Role of nanoparticles in enhancing chemotherapy efficacy for cancer treatment
by: Huma Ghazal, et al.
Published: (2024-01-01)

In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology
by: Chenkai Mao, et al.
Published: (2020-12-01)

Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy
by: Jianmin Li, et al.
Published: (2023-08-01)

An overview of the most important mechanisms and systems of targeted drug delivery
by: سید محمدجواد حسینی زاده
Published: (2016-05-01)

Innovative Design of Targeted Nanoparticles: Polymer–Drug Conjugates for Enhanced Cancer Therapy
by: Varaporn Buraphacheep Junyaprasert, et al.
Published: (2023-08-01)

Targeting cancer stem cells with polymer nanoparticles for gastrointestinal cancer treatment
by: Yao Sun, et al.
Published: (2022-10-01)

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part I: In vitro Release and Intracellular Uptake Perspective
by: Sebak AA, et al.
Published: (2020-11-01)

Plant Virus Expression Vectors: A Powerhouse for Global Health
by: Kathleen Hefferon
Published: (2017-07-01)

Smart Magnetic Drug Delivery Systems for the Treatment of Cancer
by: Angela Spoială, et al.
Published: (2023-02-01)

Review targeted drug delivery systems for norcantharidin in cancer therapy
by: Bing-Tao Zhai, et al.
Published: (2022-12-01)

Polymeric Core-Shell Nanoparticles Prepared by Spontaneous Emulsification Solvent Evaporation and Functionalized by the Layer-by-Layer Method
by: Marta Szczęch, et al.
Published: (2020-03-01)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
by: Mohd Khairul Nizam Mazlan, et al.
Published: (2021-07-01)

Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management
by: Mariam Zewail, et al.
Published: (2022-12-01)

Observability Study on Passive Target Localization by Conic–Angle Measurements
by: Taeil Suh, et al.
Published: (2021-09-01)

DNA Virus Vectors for Vaccine Production in Plants: Spotlight on Geminiviruses
by: Kathleen L. Hefferon
Published: (2014-08-01)

Antiviral Agents in Development for Zika Virus Infections
by: Mariana Baz, et al.
Published: (2019-06-01)

Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
by: Agnese Gagliardi, et al.
Published: (2021-02-01)

Lipid-based nanoparticles as drug delivery carriers for cancer therapy
by: Ibtesam Waheed, et al.
Published: (2024-04-01)

The real‐world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies
by: Agoston Gyula Szabo, et al.
Published: (2023-11-01)

Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems
by: Vijay Gyanani, et al.
Published: (2021-08-01)

Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
by: Yujie Cai, et al.
Published: (2023-01-01)

Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
by: Pengzhi Shi, et al.
Published: (2023-03-01)

Research and Application of Targeting Nano-Drugs
by: ChangXiao Liu
Published: (2011-06-01)

Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer [Corrigendum]
by: Ren S, et al.
Published: (2022-02-01)

Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits
by: Michael-Joseph Gorbet, et al.
Published: (2020-12-01)

Targeted drug delivery systems for elemene in cancer therapy: The story thus far
by: Huan Tian, et al.
Published: (2023-10-01)

Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
by: John C. Burnett, et al.
Published: (2013-01-01)

Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine
by: Rui Sun, et al.
Published: (2022-04-01)

Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications
by: Hassaan Umar, et al.
Published: (2022-07-01)

New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential
by: Ana Rita Brás, et al.
Published: (2023-06-01)

Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment
by: Divya Bharti Rai, et al.
Published: (2023-03-01)

Nanotechnology and Drug Delivery: An Update in Oncology
by: Tait Jones, et al.
Published: (2011-04-01)

Analysis on Target Detection and Classification in LTE Based Passive Forward Scattering Radar
by: Raja Syamsul Azmir Raja Abdullah, et al.
Published: (2016-09-01)

Targeted Nanomedicine to Treat Bone Metastasis
by: Isaac M. Adjei, et al.
Published: (2018-10-01)

The Risk of Sarcoidosis Misdiagnosis and the Harmful Effect of Corticosteroids When the Disease Picture Is Incomplete
by: Raluca Ioana Arcana, et al.
Published: (2023-01-01)

Immunotherapy with subcutaneous injection of immunomodulatory agent (OK-432) elicits durable response in locally advanced or relapsed cervical cancer
by: Quenny Michelle Dyan A. Alas, et al.
Published: (2019-01-01)